ISpecimen Valuation
| ISPC Stock | USD 1.48 0.06 3.90% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. iSpecimen retains a regular Real Value of $2.35 per share. The prevalent price of the firm is $1.48. Our model calculates the value of iSpecimen from evaluating the firm fundamentals such as Current Valuation of 1.04 M, return on equity of -1.09, and Return On Asset of -0.44 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting ISpecimen's valuation include:
Price Book 0.341 | Enterprise Value | Enterprise Value Ebitda 0.4291 | Price Sales 0.1427 | Enterprise Value Revenue 0.1005 |
Undervalued
Today
Please note that ISpecimen's price fluctuation is dangerous at this time. Calculation of the real value of iSpecimen is based on 3 months time horizon. Increasing ISpecimen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ISpecimen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ISpecimen Stock. However, ISpecimen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.48 | Real 2.35 | Target 5.0 | Hype 1.3 | Naive 1.36 |
The real value of ISpecimen Stock, also known as its intrinsic value, is the underlying worth of iSpecimen Company, which is reflected in its stock price. It is based on ISpecimen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ISpecimen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of iSpecimen helps investors to forecast how ISpecimen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ISpecimen more accurately as focusing exclusively on ISpecimen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ISpecimen's intrinsic value based on its ongoing forecasts of ISpecimen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ISpecimen's closest peers. If more than one evaluation category is relevant for ISpecimen we suggest using both methods to arrive at a better estimate.
ISpecimen Cash |
|
ISpecimen Valuation Trend
Comparing ISpecimen's enterprise value against its market capitalization is a good way to estimate the value of iSpecimen uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
ISpecimen Total Value Analysis
iSpecimen is currently projected to have valuation of 1.04 M with market capitalization of 1.48 M, debt of 196.24 K, and cash on hands of 23.69 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ISpecimen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.04 M | 1.48 M | 196.24 K | 23.69 M |
ISpecimen Investor Information
About 15.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.34. Some equities with similar Price to Book (P/B) outperform the market in the long run. iSpecimen recorded a loss per share of 18.01. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 16th of September 2024. Based on the analysis of ISpecimen's profitability, liquidity, and operating efficiency, iSpecimen is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.ISpecimen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ISpecimen has an asset utilization ratio of 62.76 percent. This indicates that the Company is making $0.63 for each dollar of assets. An increasing asset utilization means that iSpecimen is more efficient with each dollar of assets it utilizes for everyday operations.ISpecimen Ownership Allocation
ISpecimen retains 14.5 (percent) of its outstanding shares held by insiders and 3.71 (percent) owned by outside corporations.ISpecimen Profitability Analysis
The company reported the previous year's revenue of 9.93 M. Net Loss for the year was (11.1 M) with profit before overhead, payroll, taxes, and interest of 4.98 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ISpecimen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ISpecimen and how it compares across the competition.
About ISpecimen Valuation
The stock valuation mechanism determines ISpecimen's current worth on a weekly basis. Our valuation model uses a comparative analysis of ISpecimen. We calculate exposure to ISpecimen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ISpecimen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 5.9 M | 4.7 M | |
| Pretax Profit Margin | (1.01) | (1.06) | |
| Operating Profit Margin | (1.29) | (1.36) | |
| Net Loss | (1.01) | (1.06) | |
| Gross Profit Margin | 0.46 | 0.42 |
ISpecimen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 452.1 K |
ISpecimen Current Valuation Indicators
Valuation refers to the process of determining the present value of iSpecimen and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ISpecimen we look at many different elements of the entity such as ISpecimen's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ISpecimen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ISpecimen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ISpecimen's worth.Complementary Tools for ISpecimen Stock analysis
When running ISpecimen's price analysis, check to measure ISpecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISpecimen is operating at the current time. Most of ISpecimen's value examination focuses on studying past and present price action to predict the probability of ISpecimen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISpecimen's price. Additionally, you may evaluate how the addition of ISpecimen to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |